International Business Machines Corp (IBM) Financial Statements

IBM's financial health presents a nuanced picture for a value investor. On the positive side, the company demonstrates strong free cash flow generation with a 5.1% yield, which, while not explicitly compared to a 10-15% margin threshold, indicates solid cash conversion from its operations. Profitability metrics are robust, with a 15.7% profit margin, an 18.2% operating margin, and a Return on Equity of 32.4% that far exceeds the framework's 15-20% high-quality threshold for ROIC/ROE. Revenue growth of 12.2% YoY is consistent and double-digit, a favourable quality indicator. However, the balance sheet raises a major red flag. A debt-to-equity ratio of 1.98 is extremely high and well above the framework's favourable threshold of low/zero debt (Debt/EBITDA < 1.0x). This level of leverage introduces significant financial risk and is a critical weakness in the quality assessment. The dividend yield of 2.77% is a return of capital to shareholders, but it must be weighed against the company's substantial debt burden. Overall, the quality profile is split: strong on profitability and cash flow, but weak on financial leverage and balance sheet strength. Analysis based on data as of 2024-05-15.